X4 Pharmaceuticals (XFOR) Exchange Rate Effect (2017 - 2025)
X4 Pharmaceuticals posted quarterly Exchange Rate Effect of $3000.0 for Q4 2025, up 101.23% year-on-year from $1490.8 in Q4 2024, and up 400.0% on a QoQ basis from -$1000.0 in Q3 2025.
X4 Pharmaceuticals (XFOR) has 9 years of Exchange Rate Effect data on file, last reported at $3000.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 101.23% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2025 stood at $213000.0 (up 236.54% YoY), and the FY2025 full-year result was $213000.0, up 236.54% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $3000.0, up from -$1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $363000.0 in Q4 2022 and bottomed at -$244000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$12000.0 (2023), against an average of -$13400.0.
- The widest annual swing landed in 2022, when Exchange Rate Effect slumped 605.0%; it then soared 872.22% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$116000.0 in 2021, then soared by 412.93% to $363000.0 in 2022, then sank by 65.01% to $127000.0 in 2023, then plunged by 292.13% to -$244000.0 in 2024, then jumped by 101.23% to $3000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $3000.0 (Q4 2025), -$1000.0 (Q3 2025), and $139000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | -244,000.00 |
| Dec 31, 2024 | -244,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 363,000.00 |
| Dec 31, 2022 | 363,000.00 |
| Sep 30, 2022 | -197,000.00 |
| Sep 30, 2022 | -197,000.00 |
| Jun 30, 2022 | -202,000.00 |
| Jun 30, 2022 | -202,000.00 |
| Mar 31, 2022 | -69,000.00 |
| Mar 31, 2022 | -69,000.00 |
| Dec 31, 2021 | -116,000.00 |
| Dec 31, 2021 | -116,000.00 |
| Sep 30, 2021 | -100,000.00 |
| Sep 30, 2021 | -100,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Mar 31, 2021 | -143,000.00 |
| Mar 31, 2021 | -143,000.00 |
| Dec 31, 2020 | 162,000.00 |
| Dec 31, 2020 | 162,000.00 |
| Sep 30, 2020 | 180,000.00 |
| Sep 30, 2020 | 180,000.00 |
| Jun 30, 2020 | 94,000.00 |
| Jun 30, 2020 | 94,000.00 |
| Mar 31, 2020 | -34,000.00 |
| Mar 31, 2020 | -34,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | -264,000.00 |
| Sep 30, 2019 | -264,000.00 |
| Jun 30, 2019 | 19,000.00 |
| Jun 30, 2019 | 19,000.00 |
| Mar 31, 2019 | -21,000.00 |
| Mar 31, 2019 | -21,000.00 |
| Sep 30, 2018 | 120,000.00 |
| Sep 30, 2018 | 120,000.00 |
| Jun 30, 2018 | -137,000.00 |
| Jun 30, 2018 | -137,000.00 |
| Mar 31, 2018 | 17,000.00 |
| Mar 31, 2018 | 17,000.00 |
| Dec 31, 2017 | -402,000.00 |
| Dec 31, 2017 | -402,000.00 |
| Sep 30, 2017 | 347,000.00 |
| Sep 30, 2017 | 347,000.00 |
| Jun 30, 2017 | 43,000.00 |
| Jun 30, 2017 | 43,000.00 |
| Mar 31, 2017 | 12,000.00 |
| Mar 31, 2017 | 12,000.00 |